标题
Cannabidiol for neurodegenerative disorders: A comprehensive review
作者
关键词
-
出版物
Frontiers in Pharmacology
Volume 13, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2022-10-25
DOI
10.3389/fphar.2022.989717
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cannabidiol (CBD) treatment improves spatial memory in 14-month-old female TAU58/2 transgenic mice
- (2022) Fabian Kreilaus et al. BEHAVIOURAL BRAIN RESEARCH
- Cannabidiol Treatment Improves Glucose Metabolism and Memory in Streptozotocin-Induced Alzheimer’s Disease Rat Model: A Proof-of-Concept Study
- (2022) Daniele de Paula Faria et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Attitudes, beliefs, and changing trends of cannabidiol (CBD) oil use among caregivers of individuals with Alzheimer’s disease
- (2021) Magdalena Leszko et al. COMPLEMENTARY THERAPIES IN MEDICINE
- Cannabidiol Ameliorates Cognitive Function via Regulation of IL-33 and TREM2 Upregulation in a Murine Model of Alzheimer’s Disease
- (2021) Hesam Khodadadi et al. JOURNAL OF ALZHEIMERS DISEASE
- Neuroprotective and Symptomatic Effects of Cannabidiol in an Animal Model of Parkinson’s Disease
- (2021) Claudio Giuliano et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Novel cannabidiol−carbamate hybrids as selective BuChE inhibitors: Docking-based fragment reassembly for the development of potential therapeutic agents against Alzheimer's disease
- (2021) Xia Jiang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Preclinical Investigation in Neuroprotective Effects of the GPR55 Ligand VCE-006.1 in Experimental Models of Parkinson’s Disease and Amyotrophic Lateral Sclerosis
- (2021) Sonia Burgaz et al. MOLECULES
- The Effect of Cannabidiol Coated by Nano-Chitosan on Learning and Memory, Hippocampal CB1 and CB2 Levels, and Amyloid Plaques in an Alzheimer’s Disease Rat Model
- (2021) Mohammadali Amini et al. NEUROPSYCHOBIOLOGY
- Cannabidiol Inhibits Tau Aggregation In Vitro
- (2021) Soha Alali et al. Cells
- Chronic Treatment with 50 mg/kg Cannabidiol Improves Cognition and Moderately Reduces Aβ42 Levels in 12-Month-Old Male AβPPswe/PS1ΔE9 Transgenic Mice
- (2020) Georgia Watt et al. JOURNAL OF ALZHEIMERS DISEASE
- From Cannabis sativa to Cannabidiol: Promising Therapeutic Candidate for the Treatment of Neurodegenerative Diseases
- (2020) Tommaso Cassano et al. Frontiers in Pharmacology
- Glycogen synthase kinase-3 signaling in Alzheimer's disease
- (2020) Elisabetta Lauretti et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Pharmacotherapy of Alzheimer’s Disease: Seeking Clarity in a Time of Uncertainty
- (2020) Nurul Husna Ibrahim et al. Frontiers in Pharmacology
- Cannabidiol exerts protective effects in an in vitro model of Parkinson's disease activating AKT/mTOR pathway
- (2020) Agnese Gugliandolo et al. FITOTERAPIA
- Minutes of PPAR-γ Agonism and Neuroprotection
- (2020) B.R. Prashantha Kumar et al. NEUROCHEMISTRY INTERNATIONAL
- Interaction of Microglia and Astrocytes in the Neurovascular Unit
- (2020) Li-rong Liu et al. Frontiers in Immunology
- Cannabidiol (CBD) enhanced the hippocampal immune response and autophagy of APP/PS1 Alzheimer's mice uncovered by RNA-seq
- (2020) Fengjin Hao et al. LIFE SCIENCES
- Current Aspects of the Endocannabinoid System and Targeted THC and CBD Phytocannabinoids as Potential Therapeutics for Parkinson’s and Alzheimer’s Diseases: a Review
- (2020) R. Cooray et al. MOLECULAR NEUROBIOLOGY
- Efficacy of acetylcholinesterase inhibitors in Alzheimer's disease
- (2020) Gabriella Marucci et al. NEUROPHARMACOLOGY
- Chronic cannabidiol (CBD) treatment did not exhibit beneficial effects in 4-month-old male TAU58/2 transgenic mice
- (2020) Georgia Watt et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Towards Better Delivery of Cannabidiol (CBD)
- (2020) Sophie Anne Millar et al. Pharmaceuticals
- Medium-Dose Chronic Cannabidiol Treatment Reverses Object Recognition Memory Deficits of APPSwe/PS1ΔE9 Transgenic Female Mice
- (2020) Madilyn Coles et al. Frontiers in Pharmacology
- Amyloid β oligomers suppress excitatory transmitter release via presynaptic depletion of phosphatidylinositol-4,5-bisphosphate
- (2019) Yang He et al. Nature Communications
- Cannabidiol Enhances the Passage of Lipid Nanocapsules across the Blood–Brain Barrier Both in Vitro and in Vivo
- (2019) Juan Aparicio-Blanco et al. MOLECULAR PHARMACEUTICS
- Alzheimer’s disease: pathogenesis, diagnostics, and therapeutics
- (2019) Sneham Tiwari et al. International Journal of Nanomedicine
- Ageing as a risk factor for neurodegenerative disease
- (2019) Yujun Hou et al. Nature Reviews Neurology
- Antioxidative and Anti-Inflammatory Properties of Cannabidiol
- (2019) Sinemyiz Atalay et al. Antioxidants
- Novel insights into mitochondrial molecular targets of iron-induced neurodegeneration: Reversal by cannabidiol
- (2018) Vanessa Kappel da Silva et al. BRAIN RESEARCH BULLETIN
- Cannabidiol Reverses Deficits in Hippocampal LTP in a Model of Alzheimer’s Disease
- (2018) Blathnaid Hughes et al. NEUROCHEMICAL RESEARCH
- Cannabidiol as a Promising Strategy to Treat and Prevent Movement Disorders?
- (2018) Fernanda F. Peres et al. Frontiers in Pharmacology
- Cannabis-Based Medicine Reduces Multiple Pathological Processes in AβPP/PS1 Mice
- (2018) Ester Aso et al. JOURNAL OF ALZHEIMERS DISEASE
- Long-Term Cannabidiol Treatment Prevents the Development of Social Recognition Memory Deficits in Alzheimer's Disease Transgenic Mice
- (2018) David Cheng et al. JOURNAL OF ALZHEIMERS DISEASE
- Microglia in neurodegeneration
- (2018) Suzanne Hickman et al. NATURE NEUROSCIENCE
- ∆9-Tetrahydrocannabinol, a major marijuana component, enhances the anesthetic effect of pentobarbital through the CB1 receptor
- (2018) Toshiyuki Kimura et al. Forensic Toxicology
- Pathology of Neurodegenerative Diseases
- (2017) Brittany N. Dugger et al. Cold Spring Harbor Perspectives in Biology
- An update on PPAR activation by cannabinoids
- (2016) Saoirse Elizabeth O'Sullivan BRITISH JOURNAL OF PHARMACOLOGY
- An update on the diagnosis and treatment of Parkinson disease
- (2016) Philippe Rizek et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Delineating the Efficacy of a Cannabis-Based Medicine at Advanced Stages of Dementia in a Murine Model
- (2016) Ester Aso et al. JOURNAL OF ALZHEIMERS DISEASE
- Cannabinoid Receptor 2 Participates in Amyloid-β Processing in a Mouse Model of Alzheimer’s Disease but Plays a Minor Role in the Therapeutic Properties of a Cannabis-Based Medicine
- (2016) Ester Aso et al. JOURNAL OF ALZHEIMERS DISEASE
- Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial
- (2016) Orrin Devinsky et al. LANCET NEUROLOGY
- Therapeutic potential of cannabis-related drugs
- (2016) Stephen P.H. Alexander PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Neurodegeneration: From cellular concepts to clinical applications
- (2016) A. Katsnelson et al. Science Translational Medicine
- Critical Role of Mast Cells and Peroxisome Proliferator–Activated Receptor γ in the Induction of Myeloid-Derived Suppressor Cells by Marijuana Cannabidiol In Vivo
- (2015) Venkatesh L. Hegde et al. JOURNAL OF IMMUNOLOGY
- Interrelation of Oxidative Stress and Inflammation in Neurodegenerative Disease: Role of TNF
- (2015) Roman Fischer et al. Oxidative Medicine and Cellular Longevity
- The neuroprotection of cannabidiol against MPP + -induced toxicity in PC12 cells involves trkA receptors, upregulation of axonal and synaptic proteins, neuritogenesis, and might be relevant to Parkinson's disease
- (2015) Neife Aparecida Guinaim Santos et al. TOXICOLOGY IN VITRO
- Cannabidiol can improve complex sleep-related behaviours associated with rapid eye movement sleep behaviour disorder in Parkinson's disease patients: a case series
- (2014) M. H. N. Chagas et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Effects of cannabidiol in the treatment of patients with Parkinson’s disease: An exploratory double-blind trial
- (2014) Marcos Hortes N Chagas et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Chronic cannabidiol treatment improves social and object recognition in double transgenic APPswe/PS1∆E9 mice
- (2014) David Cheng et al. PSYCHOPHARMACOLOGY
- Increase of mesenchymal stem cell migration by cannabidiol via activation of p42/44 MAPK
- (2013) Ellen Schmuhl et al. BIOCHEMICAL PHARMACOLOGY
- Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer's disease
- (2013) Zhiyou Cai et al. INTERNATIONAL JOURNAL OF NEUROSCIENCE
- Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy
- (2013) Chia-Chen Liu et al. Nature Reviews Neurology
- Cannabidiol Promotes Amyloid Precursor Protein Ubiquitination and Reduction of Beta Amyloid Expression in SHSY5YAPP+Cells Through PPARγ Involvement
- (2013) Caterina Scuderi et al. PHYTOTHERAPY RESEARCH
- A induces astrocytic glutamate release, extrasynaptic NMDA receptor activation, and synaptic loss
- (2013) M. Talantova et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid?
- (2012) Javier Fernández-Ruiz et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Inhibition of GSK3β-mediated BACE1 expression reduces Alzheimer-associated phenotypes
- (2012) Philip T.T. Ly et al. JOURNAL OF CLINICAL INVESTIGATION
- The PPAR-gamma agonist pioglitazone protects cortical neurons from inflammatory mediators via improvement in peroxisomal function
- (2012) Elizabeth Gray et al. Journal of Neuroinflammation
- Genetic insights in Alzheimer's disease
- (2012) Karolien Bettens et al. LANCET NEUROLOGY
- Biphasic Effects of Cannabinoids in Anxiety Responses: CB1 and GABAB Receptors in the Balance of GABAergic and Glutamatergic Neurotransmission
- (2012) Alejandro Aparisi Rey et al. NEUROPSYCHOPHARMACOLOGY
- A novel glycogen synthase kinase-3 inhibitor 2-methyl-5-(3-{4-[(S )-methylsulfinyl]phenyl}-1-benzofuran-5-yl)-1,3,4-oxadiazole decreases tau phosphorylation and ameliorates cognitive deficits in a transgenic model of Alzheimer’s disease
- (2011) Tomohiro Onishi et al. JOURNAL OF NEUROCHEMISTRY
- Cannabidiol and Other Cannabinoids Reduce Microglial Activation In Vitro and In Vivo: Relevance to Alzheimer's Disease
- (2011) A. M. Martin-Moreno et al. MOLECULAR PHARMACOLOGY
- Cannabidiol Reduces Aβ-Induced Neuroinflammation and Promotes Hippocampal Neurogenesis through PPARγ Involvement
- (2011) Giuseppe Esposito et al. PLoS One
- Mechanisms Underlying Inflammation in Neurodegeneration
- (2010) Christopher K. Glass et al. CELL
- Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders
- (2010) Giles E. Hardingham et al. NATURE REVIEWS NEUROSCIENCE
- Rosiglitazone Rescues Memory Impairment in Alzheimer's Transgenic Mice: Mechanisms Involving a Reduced Amyloid and Tau Pathology
- (2010) Luis Escribano et al. NEUROPSYCHOPHARMACOLOGY
- Time-dependent vascular actions of cannabidiol in the rat aorta
- (2009) Saoirse E. O'Sullivan et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Cannabinoids Δ9-Tetrahydrocannabinol and Cannabidiol Differentially Inhibit the Lipopolysaccharide-activated NF-κB and Interferon-β/STAT Proinflammatory Pathways in BV-2 Microglial Cells
- (2009) Ewa Kozela et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cannabidiol ameliorates cognitive and motor impairments in mice with bile duct ligation
- (2009) Iddo Magen et al. JOURNAL OF HEPATOLOGY
- On the mechanism of internalization of α-synuclein into microglia: roles of ganglioside GM1 and lipid raft
- (2009) Ji-Young Park et al. JOURNAL OF NEUROCHEMISTRY
- Low-density lipoprotein receptors regulate microglial inflammation through c-Jun N-terminal kinase
- (2008) Ana Pocivavsek et al. GLIA
- Mitochondrial Import and Accumulation of α-Synuclein Impair Complex I in Human Dopaminergic Neuronal Cultures and Parkinson Disease Brain
- (2008) Latha Devi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Nitrated Alpha-Synuclein and Microglial Neuroregulatory Activities
- (2008) Ashley D. Reynolds et al. Journal of Neuroimmune Pharmacology
- Interactions between APP secretases and inflammatory mediators
- (2008) Magdalena Sastre et al. Journal of Neuroinflammation
- Cannabidiol for the treatment of psychosis in Parkinson’s disease
- (2008) AW Zuardi et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Genetics, environmental factors and the emerging role of epigenetics in neurodegenerative diseases
- (2008) Lucia Migliore et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
- β-catenin is required for memory consolidation
- (2008) Kimberly A Maguschak et al. NATURE NEUROSCIENCE
- The diverse CB1and CB2receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin
- (2007) R G Pertwee BRITISH JOURNAL OF PHARMACOLOGY
- Cannabidiol in vivo blunts β-amyloid induced neuroinflammation by suppressing IL-1β and iNOS expression
- (2007) G Esposito et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro
- (2007) A Thomas et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabinoid pharmacology: the first 66 years
- (2006) Roger G Pertwee BRITISH JOURNAL OF PHARMACOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started